A
Metabolic syndrome
61
evidence score
PREVENT status
Not a PREVENT input variable.
Causal support
trial evidence
Score components
lit volume: 25.6meta-analyses: 20trials: 15genetic: 0MR bonus:
References (358)
18 meta-analyses / systematic reviews- METAIncreased atherogenicity in mood disorders: a systematic review, meta-analysis and meta-regression. — Neuroscience and biobehavioral reviews 2025 · PMID 39793682
- METAGlobal incidence of adverse clinical events in non-alcoholic fatty liver disease: A systematic review and meta-analysis. — Clinical and molecular hepatology 2024 · PMID 38281814
- METAUltra-processed food consumption and human health: an umbrella review of systematic reviews with meta-analyses. — Critical reviews in food science and nutrition 2024 · PMID 38363072
- METAShifting Rhythms: A Systematic Review Exploring the Multifaceted Effects of Shift Work and Circadian Disruption on Employee Cardiovascular Health. — Cureus 2024 · PMID 39507145
- METAShift work and the risk for metabolic syndrome among healthcare workers: A systematic review and meta-analysis. — Obesity reviews : an official journal of the International Association for the Study of Obesity 2022 · PMID 35734805
- METAAssociation Between Cardiovascular Risk Factors and Cognitive Impairment in People With Schizophrenia: A Systematic Review and Meta-analysis. — JAMA psychiatry 2021 · PMID 33656533
- METALong-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis. — Human reproduction update 2020 · PMID 32995872
- METASystematic review of shift work and nurses' health. — Occupational medicine (Oxford, England) 2019 · PMID 31132107
- METASocio-economics status and metabolic syndrome: A meta-analysis. — Diabetes & metabolic syndrome 2019 · PMID 31235098
- METAAerobic, resistance or combined training: A systematic review and meta-analysis of exercise to reduce cardiovascular risk in adults with metabolic syndrome. — Atherosclerosis 2018 · PMID 29783064
- METAAssociation of Hepatic Steatosis With Subclinical Atherosclerosis: Systematic Review and Meta-Analysis. — Hepatology communications 2018 · PMID 30094399
- METAAssociation of Psoriasis With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. — JAMA dermatology 2018 · PMID 30422277
- METARisk factors for intracranial atherosclerosis: A systematic review and meta-analysis. — Atherosclerosis 2018 · PMID 30658194
- METASedentary behavior and health outcomes: an overview of systematic reviews. — PloS one 2014 · PMID 25144686
- METAMeta-analysis of psoriasis, cardiovascular disease, and associated risk factors. — Journal of the American Academy of Dermatology 2013 · PMID 24238156
- METASystematic review of sedentary behaviour and health indicators in school-aged children and youth. — The international journal of behavioral nutrition and physical activity 2011 · PMID 21936895
- METACardiovascular risk factors in patients with plaque psoriasis: a systematic review of epidemiological studies — Journal of the European Academy of Dermatology and Venereology 2010 · PMID 20443997
- METAMetabolic syndrome and risk of cardiovascular disease: a meta-analysis. — The American journal of medicine 2006 · PMID 17000207
- Metabolic dysfunction-associated steatotic liver disease and the cardiovascular system. — Trends in cardiovascular medicine 2025 · PMID 39848507
- Correlation between atherogenic index of plasma and cardiovascular disease risk across Cardiovascular-kidney-metabolic syndrome stages 0-3: a nationwide prospective cohort study. — Cardiovascular diabetology 2025 · PMID 39856691
- Effects of the Mediterranean Diet on the Components of Metabolic Syndrome Concerning the Cardiometabolic Risk. — Nutrients 2025 · PMID 39861488
- The prevention and management of chronic kidney disease among patients with metabolic syndrome. — Kidney international 2025 · PMID 39986466
- Hyperuricemia and Cardiovascular Risk: Insights and Implications. — Critical pathways in cardiology 2025 · PMID 40062919
- The prognostic significance of stress hyperglycemia ratio in evaluating all-cause and cardiovascular mortality risk among individuals across stages 0-3 of cardiovascular-kidney-metabolic syndrome: evidence from two cohort studies. — Cardiovascular diabetology 2025 · PMID 40128747
- Overall Sleep Quality Is Associated With Advanced Stages in Patients With Cardiovascular-Kidney-Metabolic Syndrome. — Journal of the American Heart Association 2025 · PMID 40130386
- Risk-Based Primary Prevention of Heart Failure: A Scientific Statement From the American Heart Association. — Circulation 2025 · PMID 40235437
- Integrative metabolomics and genomics reveal molecular signatures for type 2 diabetes and its cardiovascular complications. — Cardiovascular diabetology 2025 · PMID 40241080
- Association between remnant cholesterol and the risk of cardiovascular-kidney-metabolic syndrome progression: insights from the China health and retirement longitudinal study. — European journal of preventive cardiology 2025 · PMID 40272444
- Lithium in cardiovascular health and disease: Pharmacological and clinical implications. — European journal of pharmacology 2025 · PMID 40324573
- Life's Essential 8 cardiovascular health, cardiovascular-kidney-metabolic syndrome stages, and incident cardiovascular events: a nationwide 10-year prospective cohort study in China. — Cardiovascular diabetology 2025 · PMID 40346555
- Sex-specific cardiometabolic multimorbidity, metabolic syndrome and left ventricular function in heart failure with preserved ejection fraction in the UK Biobank. — Cardiovascular diabetology 2025 · PMID 40468351
- Association between the cardiometabolic index and cardiovascular disease risk in patients with cardiovascular-kidney-metabolic syndrome: a cohort study. — BMC cardiovascular disorders 2025 · PMID 40610957
- Epicardial fat tissue in metabolically healthy and unhealthy obesity: culprit or bystander? — Minerva endocrinology 2025 · PMID 40635457
- Cardiometabolic risk phenotypes and chronic kidney disease incidence in older adults: a nationwide longitudinal cohort study. — BMC public health 2025 · PMID 40730993
- The Visceral Adiposity Index and Its Usefulness in the Prediction of Cardiometabolic Disorders. — Nutrients 2025 · PMID 40732999
- Sleep Irregularity, Circadian Disruption, and Cardiometabolic Disease Risk. — Circulation research 2025 · PMID 40811504
- Cadmium exposure and advanced cardiovascular-kidney-metabolic syndrome: An integrated multi-organ perspective based on epidemiology and adverse outcome pathways. — Ecotoxicology and environmental safety 2025 · PMID 40819402
- Evaluative performance of TyG-ABSI versus traditional indices in relation to cardiovascular disease and mortality: evidence from the U.S. NHANES. — Cardiovascular diabetology 2025 · PMID 40841630
- Skeletal Muscle and Cardiovascular Health. — Advances in experimental medicine and biology 2025 · PMID 40879958
- Alcohol consumption, high-sensitivity C-reactive protein, and estimated glomerular filtration rate: tripartite predictors of 10-year cardiovascular risk progression in patients with type 2 diabetes mellitus after COVID-19. — Frontiers in endocrinology 2025 · PMID 40933377
- Association of the triglyceride-glucose index combined with a body shape index with all-cause and cardiovascular mortality in individuals with cardiovascular-kidney-metabolic syndrome stage 0-3: findings from two prospective cohorts. — Cardiovascular diabetology 2025 · PMID 40988017
- Polycystic ovary syndrome in 2025-insights and innovations. — Fertility and sterility 2025 · PMID 40992713
- Relationship between moderate alcohol consumption and all-cause mortality across different stages of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: a cohort study. — Nutrition, metabolism, and cardiovascular diseases : NMCD 2025 · PMID 41076328
- Metabolic Syndrome-Associated Erectile Dysfunction: Multiple Vascular Endothelial Dysfunction Mechanisms and Potential Therapeutic Targets. — International journal of biological sciences 2025 · PMID 41079939
- Physical activity and cardiovascular-metabolic disease risk across cardiovascular-kidney-metabolic syndrome stages: a population-based cohort study. — BMC cardiovascular disorders 2025 · PMID 41120873
- Air pollution exacerbates cardiovascular-kidney-metabolic syndrome and sarcopenia comorbidity via shared genetic-epigenetic mechanisms: A multi-omics and Mendelian Randomization study. — Metabolism: clinical and experimental 2025 · PMID 41270966
- Association between the atherogenic index of plasma and major adverse cardiovascular events in individuals with metabolic syndrome: findings from the UK biobank. — Cardiovascular diabetology 2025 · PMID 41272658
- Heavy metals and mortality in cardiovascular-kidney-metabolic syndrome: Insights from the NHANES cohort. — Medicine 2025 · PMID 41367030
- Remnant cholesterol inflammatory index and cardiovascular disease among adults with cardiovascular-kidney-metabolic syndrome stages 0-3: a nationwide prospective cohort study. — Scientific reports 2025 · PMID 41381692
- 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association — Circulation 2024 · PMID 38264914
- The Pathophysiological Associations Between Obesity, NAFLD, and Atherosclerotic Cardiovascular Diseases. — Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 2024 · PMID 38471571
- Galectin-3, Metabolic Risk, and Incident Heart Failure: The ARIC Study. — Journal of the American Heart Association 2024 · PMID 38471823
- A Possible Therapeutic Application of the Selective Inhibitor of Urate Transporter 1, Dotinurad, for Metabolic Syndrome, Chronic Kidney Disease, and Cardiovascular Disease. — Cells 2024 · PMID 38474414
- Cystatin C Is a Predictor for Long-Term, All-Cause, and Cardiovascular Mortality in US Adults With Metabolic Syndrome. — The Journal of clinical endocrinology and metabolism 2024 · PMID 38597157
- Association between triglyceride-glucose related indices with the all-cause and cause-specific mortality among the population with metabolic syndrome. — Cardiovascular diabetology 2024 · PMID 38658993
- Lipid Toxicity in the Cardiovascular-Kidney-Metabolic Syndrome (CKMS). — Biomedicines 2024 · PMID 38790940
- Triglyceride-rich lipoproteins and cardiovascular diseases. — Frontiers in endocrinology 2024 · PMID 38883601
- Coffee consumption and cardiometabolic health: a comprehensive review of the evidence. — GeroScience 2024 · PMID 38963648
- Uric acid and cardiovascular diseases: a reappraisal. — Postgraduate medicine 2024 · PMID 38973128
- Integrated single cell-RNA sequencing and Mendelian randomization for ischemic stroke and metabolic syndrome. — iScience 2024 · PMID 39021802
- The effect of dietary approaches to stop hypertension (DASH) diet on fatty liver and cardiovascular risk factors in subjects with metabolic syndrome: a randomized controlled trial. — BMC endocrine disorders 2024 · PMID 39054440
- Machine Learning-Assisted Analysis of Sublingual Microcirculatory Dysfunction for Early Cardiovascular Risk Evaluation and Cardiovascular-Kidney-Metabolic Syndrome Stage in Patients With Type 2 Diabetes Mellitus. — Diabetes/metabolism research and reviews 2024 · PMID 39081178
- Association between the triglyceride glucose-body mass index and future cardiovascular disease risk in a population with Cardiovascular-Kidney-Metabolic syndrome stage 0-3: a nationwide prospective cohort study. — Cardiovascular diabetology 2024 · PMID 39113004
- Genetic association between post-traumatic stress disorder and cardiovascular disease: A scoping review. — Journal of psychiatric research 2024 · PMID 39191203
- The Influence of Physical Activity and Diet Mobile Apps on Cardiovascular Disease Risk Factors: Meta-Review. — Journal of medical Internet research 2024 · PMID 39382958
- Metabolic Syndrome, Thyroid Dysfunction, and Cardiovascular Risk: The Triptych of Evil. — International journal of molecular sciences 2024 · PMID 39408957
- [Gout and Nutrition]. — Therapeutische Umschau. Revue therapeutique 2024 · PMID 39508812
- Partitioned polygenic risk scores identify distinct types of metabolic dysfunction-associated steatotic liver disease. — Nature medicine 2024 · PMID 39653778
- Insights into renal damage in hyperuricemia: Focus on renal protection (Review). — Molecular medicine reports 2024 · PMID 39717954
- Biologics for Reducing Cardiovascular Risk in Psoriasis Patients — Journal of Clinical Medicine 2023 · PMID 36769825
- A Potential Strategy for Atherosclerosis Prevention in Modernizing China - Hyperhomocysteinemia, MTHFR C677T Polymorphism and Air Pollution (PM2.5) on Atherogenesis in Chinese Adults. — The journal of nutrition, health & aging 2023 · PMID 36806868
- Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: Causation or Association. — Cardiology in review 2023 · PMID 36825899
- Remnant cholesterol, vascular risk, and prevention of atherosclerosis. — Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis 2023 · PMID 36889989
- The Triglyceride/High-Density Lipoprotein Cholesterol (TG/HDL-C) Ratio as a Risk Marker for Metabolic Syndrome and Cardiovascular Disease — Diagnostics 2023 · PMID 36900073
- Metabolic syndrome predicts cardiovascular risk and mortality in familial hypercholesterolemia. — Journal of clinical lipidology 2023 · PMID 37003850
- Androgenetic alopecia: Traditional cardiovascular risk factors, metabolic syndrome, and component traits among Nigerian adults. — Nigerian journal of clinical practice 2023 · PMID 37203111
- Yoga practice can reduce metabolic syndrome and cardiovascular risk in climacteric women. — Journal of behavioral medicine 2023 · PMID 37294473
- Increased ultra-processed food consumption is associated with worsening of cardiometabolic risk factors in adults with metabolic syndrome: Longitudinal analysis from a randomized trial. — Atherosclerosis 2023 · PMID 37343432
- Visceral fat and cardiometabolic future in children and adolescents: a critical update. — Pediatric research 2023 · PMID 37402844
- 8-Aminopurines in the Cardiovascular and Renal Systems and Beyond. — Hypertension (Dallas, Tex. : 1979) 2023 · PMID 37503660
- Apolipoprotein B compared with low-density lipoprotein cholesterol in the atherosclerotic cardiovascular diseases risk assessment. — Pharmacological research 2023 · PMID 37517561
- Sleep Deficiency and Cardiometabolic Disease. — Sleep medicine clinics 2023 · PMID 37532373
- Established and potential cardiovascular risk factors in metabolic syndrome: Effect of bariatric surgery. — Current opinion in lipidology 2023 · PMID 37560987
- Non-HDL cholesterol and long-term follow-up outcomes in patients with metabolic syndrome. — Lipids in health and disease 2023 · PMID 37794473
- A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement From the American Heart Association — Circulation 2023 · PMID 37807920
- Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association — Circulation 2023 · PMID 37807924
- Evaluation and treatment of metabolic syndrome and cardiovascular disease in adult patients with psoriasis. — International journal of dermatology 2023 · PMID 37845786
- Insights into the Role of Galectin-3 as a Diagnostic and Prognostic Biomarker of Atrial Fibrillation. — Disease markers 2023 · PMID 37849915
- Addressing dyslipidemic risk beyond LDL-cholesterol. — The Journal of clinical investigation 2022 · PMID 34981790
- Glycoprotein Acetyls: A Novel Inflammatory Biomarker of Early Cardiovascular Risk in the Young — Journal of the American Heart Association 2022 · PMID 35156387
- Cardiovascular Disease-Associated Skin Conditions. — Vascular health and risk management 2022 · PMID 35210782
- Psoriasis and metabolic syndrome: implications for the management and treatment of psoriasis. — Journal of the European Academy of Dermatology and Venereology : JEADV 2022 · PMID 35238067
- Uric Acid and Oxidative Stress—Relationship with Cardiovascular, Metabolic, and Renal Impairment — International Journal of Molecular Sciences 2022 · PMID 35328614
- Sleep Deficiency and Cardiometabolic Disease. — Clinics in chest medicine 2022 · PMID 35659028
- Migrating Populations and Health: Risk Factors for Cardiovascular Disease and Metabolic Syndrome. — Current hypertension reports 2022 · PMID 35704140
- Metabolic syndrome and cardiovascular risk between clozapine and non-clozapine antipsychotic users with schizophrenia. — Asian journal of psychiatry 2022 · PMID 35751958
- Lifestyle and metabolic risk factors in patients with early-onset myocardial infarction: a case-control study. — European journal of preventive cardiology 2022 · PMID 35776839
- The Gut Microbiota (Microbiome) in Cardiovascular Disease and Its Therapeutic Regulation. — Frontiers in cellular and infection microbiology 2022 · PMID 35795187
- Association between a dietary pattern high in saturated fatty acids, dietary energy density, and sodium with coronary heart disease. — Scientific reports 2022 · PMID 35906378
- Periodontal therapy for primary or secondary prevention of cardiovascular disease in people with periodontitis — Cochrane Database of Systematic Reviews 2022 · PMID 36194420
Clinical trials (85)
showing top 60| NCT | Title | Status | Type | Interventions |
|---|---|---|---|---|
| NCT07027995 | Food and Fitness With Medicine | RECRUITING | INTERVENTIONAL | Exercise is Medicine (EIM), Culinary Education, Food is Medicine |
| NCT06966258 | Inspire HER: Inspiring the Heart and Emotions for Radical Health | RECRUITING | INTERVENTIONAL | Inspire HER Intervention |
| NCT07361887 | Deciphering the Effect of Moderate Wine Consumption on Healthy Aging Through Postprandial Extracellular Vesicles | RECRUITING | INTERVENTIONAL | White Wine, Red Wine, Water |
| NCT06271200 | Effects of Intensive Lifestyle Interventions (ILI) on Weight Loss and Cardiometabolic Risks in Obese Adults With Metabolic Syndrome: A Randomized Clinical Trial | RECRUITING | INTERVENTIONAL | Strategic lifestyle and drug interventions, Control |
| NCT06112418 | A Randomized Comparison of Cleerly Coronary Artery Disease Stage-Based Care Versus Risk Factor-Based Care for Primary Prevention of Cardiovascular Events | RECRUITING | INTERVENTIONAL | The Cleerly CAD Staging System |
| NCT06172335 | Effects of Ketolic Acid on Atherosclerosis Markers in High-risk Patients With Metabolic Syndrome (Effekt av Ketolinsyre på aterosklerosemarkører i høyrisikopasienter Med Metabolsk Syndrom) | RECRUITING | INTERVENTIONAL | Cetoleic acid, Control oil |
| NCT06055036 | Black Impact: The Mechanisms Underlying Psychosocial Stress Reduction in a Cardiovascular Health Intervention | RECRUITING | INTERVENTIONAL | Black Impact Intervention |
| NCT05845424 | Comparison of Efficacy and Safety of High-Intensity Statin and Ezetimibe Combination Versus StanDard carE in AsymptomatiC PatIentS wIth Presence of COroNary Artery CALCIUM (DECISION-CAL) | RECRUITING | INTERVENTIONAL | Guideline directed statin therapy, High intensity statin plus ezetimibe therapy |
| NCT07551960 | Design, Development and Pilot Validation of an Interventional System of the STELA Center for Preventive Medicine to Reduce Modifiable Health Risk Factors in the Adult Population (CPM-STELA) | ENROLLING BY INVITATION | INTERVENTIONAL | STELA Digital Preventive Medicine Platform, Comprehensive Preventive Health Assessment |
| NCT07209527 | Evaluation of Truway Health-Sourced Portable Diagnostic Devices for Early Detection of Chronic Conditions in Outpatient Primary Care Settings: A Prospective Interventional Study | ENROLLING BY INVITATION | INTERVENTIONAL | Truway Portable Ultrasound Device, Truway Blood Glucose Monitor, Standard Oral Hypoglycemic Agent |
| NCT07065357 | Treating the Metabolic Syndrome With a Sodium-glucose Cotransporter-2 Inhibitor: a Randomised Controlled Trial | ENROLLING BY INVITATION | INTERVENTIONAL | Empagliflozin (oral), Matching placebo |
| NCT07563647 | A Randomized, Allocation-concealed, Assessor-blinded, Parallel-group Trial Evaluating the Association Between Erectile Dysfunction and Left Ventricular Diastolic Dysfunction and Comparing the Effects of Tadalafil, SGLT2 Inhibitors, and Their Combination in Patients With Metabolic Syndrome. | COMPLETED | INTERVENTIONAL | Tadalafil 5 mg, SGLT-2 inhibitor, Tadalafil plus SGLT2 inhibitors |
| NCT06051461 | Deciphering the Role of Dietary Fatty Acids on Extracellular Vesicles-mediated Intercellular Communication and Their Implication in Atherosclerosis and Metabolic Syndrome: a Multi-omics Approach to Precision Nutrition | ACTIVE NOT RECRUITING | INTERVENTIONAL | Oral lipid emulsions |
| NCT04477590 | Optimizing Exercise Training Effects on Metabolic Syndrome Factors by Altering the Timing of Medication and Meal Ingestion | UNKNOWN | INTERVENTIONAL | EXERCISE TRAINING WITH OR WITHOUT MEDICATION |
| NCT05259475 | Ectopic Fat in Singaporean Women - the Culprit Leading to Gestational Diabetes, Metabolic Syndrome, and Type 2 Diabetes | COMPLETED | INTERVENTIONAL | Lifestyle Advice, Diet Intervention, OCFA Meal-Based Diet-Intervention |
| NCT05565976 | Dapagliflozin Effect in Cognitive Impairment in Stroke Trial | UNKNOWN | INTERVENTIONAL | Dapagliflozin 10mg Tab, Statins (Cardiovascular Agents), Platelet Antiaggregant |
| NCT04321018 | Effect of the Addition of Medium Chain Triglycerides to a Mixed Macronutritional Meal on the Oxidation of Postprandial Macronutrients | UNKNOWN | INTERVENTIONAL | Mixed meal with medium chain triglycerides, Mixed meal with the replacement of medium chain triglycerides with unsaturated tryglicerides |
| NCT04959318 | Precision Nutrition Impact on Health-Related Behavior Change in Active Duty Service Members | COMPLETED | INTERVENTIONAL | Professional nutrition counseling, No professional nutrition counseling |
| NCT03877003 | Plasma TMAO and Choline Levels in Individuals With Metabolic Syndrome - Comparison Between Eggs and Choline Supplement Intake | COMPLETED | INTERVENTIONAL | Eggs |
| NCT03420989 | Development of a Novel Healthy Snacks Including Seaweeds and Carob Which Improve Risk Factors Associated With Metabolic Syndrome | COMPLETED | INTERVENTIONAL | Active snack food, Control snack food |
| NCT03921853 | Preventing Metabolic Syndrome in Patients With Morbid Obesity by Resistance Training: Reporting Non-responder Prevalence | COMPLETED | INTERVENTIONAL | Behavioral |
| NCT05423457 | Effectiveness of Vegan Diet and MyPlate Diet (Taiwanese Version) on Lipoproteins, Novel Markers of Cardiovascular Diseases, and Traditional Cardiometabolic Risk Factors | COMPLETED | INTERVENTIONAL | Vegan diet |
| NCT02858102 | Impact From Aerobic Exercise (a Program of Physical Activity) in the Metabolic Syndrome, Neurocognition and Empowerment in Individuals With Severe Mental Disorders Including Depression, Bipolar Disorder and Psychosis: a Longitudinal Study | UNKNOWN | INTERVENTIONAL | Physical activity program |
| NCT02660047 | Magnetic Resonance Assessment of Victoza Efficacy in the Regression of Cardiovascular Dysfunction In Type 2 Diabetes Mellitus and South Asian Descent | COMPLETED | INTERVENTIONAL | Liraglutide, Liraglutide - Placebo |
| NCT02404207 | The Effect of High-Oleic Soybean Oil on Biomarkers of Risk for Metabolic Syndrome | COMPLETED | INTERVENTIONAL | Soybean oil, High-oleic soybean oil, High-oleic soybean oil + fully hydrogenated soybean oil |
| NCT02117661 | ECoM Study: Effect of Carnitine Supplementation on Progression of Carotid Plaque in the Metabolic Syndrome. | COMPLETED | INTERVENTIONAL | L-carnitine capsules, Cellulose capsules |
| NCT02091583 | Developing and Evaluating a Novel Food Supplement, Consisting of Canola Oil, Fibre and DHA, Aiming at the Management of CVD Risk in a Population With Metabolic Syndrome | COMPLETED | INTERVENTIONAL | Butter, sunflower and safflower oil, High Oleic Canola Oil and DHA (HOCO-DHA), Barley beta-glucan |
| NCT02616471 | Effect of High Cheese Consumption on Metabolic Syndrome Risk Factors in a Metabolically Vulnerable Population | COMPLETED | INTERVENTIONAL | High-fat cheese, Low-fat cheese, No-cheese/carbohydrate |
| NCT02075307 | Highbush Blueberries, the DNA-damage of Obesity, Somatic Mutations and Metabolic Syndrome | COMPLETED | INTERVENTIONAL | Blueberry Powder, Placebo |
| NCT02233088 | A Pilot Study of a Lifestyle Intervention on the Metabolic Syndrome | COMPLETED | INTERVENTIONAL | ELM Group, ELM Classes, ELM Individual |
| NCT02288572 | Mechanisms of Action of Probiotic and Protective Bacteria PCS 20, PCS 26, and LGG in Prevention of the Metabolic Syndrome | COMPLETED | INTERVENTIONAL | Lactobacillus plantarum PCS 26, Placebo |
| NCT01594333 | A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome | COMPLETED | INTERVENTIONAL | Methotrexate, Placebo |
| NCT04208308 | Comparison of Effect of Animal and Plant Sources of Omega-3 PUFA in Prevention of Cardiovascular and Metabolic Diseases | UNKNOWN | INTERVENTIONAL | Chia seeds supplementation (25 g), Chia seeds supplementation (15 g), Combine supplementation: chia seeds (15g) and fish oil Maxi Cor 70+20 |
| NCT01889368 | Effect of a Grape Seed Extract (GSE) on Insulin Resistance | COMPLETED | INTERVENTIONAL | Grape Seed Extract, Placebo |
| NCT02137421 | Effects of Resveratrol on Crosstalk Between Canonical β-catenin/Wnt and FOXO Pathways in Coronary Artery Disease Patients With Metabolic Syndrome: A Case Control Study | COMPLETED | INTERVENTIONAL | Resveratrol (3, 4´, 5 trihydroxystilbene) |
| NCT02114892 | Effect of Resveratrol Administration on Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion | COMPLETED | INTERVENTIONAL | Resveratrol, Placebo |
| NCT02061267 | OLIVE OIL ON NAMPT AND ITS RELATION WITH POSTPRANDIAL INFLAMMATION AND ATHEROSCLEROSIS IN THE SETTING OF METABOLIC SYNDROME. The OLNAMS Project | COMPLETED | INTERVENTIONAL | Niacin, Saturated meal, Monounsaturated meal |
| NCT01094158 | A Phase II Placebo Controlled Randomised Study of Aramchol on Liver Triglyceride in Patients With Steatosis Due to NAFLD or NASH | COMPLETED | INTERVENTIONAL | Aramchol, Aramchol, Placebo |
| NCT00817843 | Multicenter,Double Blind,Randomized, 2-period, Crossover Study to Compare Ezetimibe/Simvastatin (10mg/10 mg) Combination Tablet Versus Simvastatin 80mg Tablet on Postprandial Arterial Endothelial Function in Patients With Metabolic Syndrome | COMPLETED | INTERVENTIONAL | Simvastatin, Simvastatin/Ezetimibe |
| NCT01099306 | Pharmacist - Physician Collaborative Approach to the Management of Metabolic Syndrome | COMPLETED | INTERVENTIONAL | Pharmaceutical care services |
| NCT00857298 | Effect of Diet-induced Weight Loss on HIV-associated Metabolic Syndrome | COMPLETED | INTERVENTIONAL | Dietary Intervention |
| NCT01806506 | Randomized Clinical Trial Comparing Laparoscopic Sleeve Gastrectomy and Gastric Bypass for Morbid Obesity and Underlying Metabolic and Hormonal Abnormalities | COMPLETED | INTERVENTIONAL | Laparoscopic sleeve gastrectomy, Roux-en-Y Gastric Bypass |
| NCT00943254 | Metabolic Syndrome: Impact of Receiving the Diagnosis and Education Intervention on Cardiovascular Risk Factor Modification and Willingness to Change | COMPLETED | INTERVENTIONAL | High-Tech Education, Low-Tech Education |
| NCT00477191 | Effects of TNF-alpha Antagonism (Etanercept) in Patients With the Metabolic Syndrome and Psoriasis | TERMINATED | INTERVENTIONAL | Etanercept |
| NCT00508937 | The Effects of Increased Dietary Protein Intake on Insulin Sensitivity in Stable Weight Individuals, Independent of Dietary Content of Carbohydrate and Saturated Fat | COMPLETED | INTERVENTIONAL | Diet, Diet, Diet |
| NCT00314561 | The Effect of Pioglitazone and Rosiglitazone on Atherosclerotic and Inflammatory Markers in Patients With Metabolic Syndrome: A Prospective, Randomized, Open-label, Crossover Trial | COMPLETED | INTERVENTIONAL | Pioglitazone, Rosiglitazone |
| NCT00327002 | A Mechanistic Study of the Effects of LY518674 on HDL C Metabolism | COMPLETED | INTERVENTIONAL | LY518674 |
| NCT00228176 | Randomized, Multicenter, Double-blind, Placebo-controlled, Two-arm Parallel Group Trial of Rimonabant 20-mg od, for Inhibition of Atherosclerosis Progression Assessed by Carotid Artery Intima-media Thickness (CIMT), in Overweight Patients With Additional Risk Factors | TERMINATED | INTERVENTIONAL | Rimonabant, Placebo (for Rimonabant) |
| NCT00659828 | Effects of Leptin Replacement in Children | COMPLETED | INTERVENTIONAL | Recombinant methionyl human leptin |
| NCT00204412 | Effectiveness of Flax Lignan and Exercise Training for Improving Lipid Profiles | COMPLETED | INTERVENTIONAL | Flax lignan, Exercise (walking) |
| NCT00269646 | Effect of a Low-Carbohydrate and High-Carbohydrate, High-Fiber Diet on Insulin Sensitivity and Risk Markers for Cardiovascular Disease in Men and Women With the Metabolic Syndrome | UNKNOWN | INTERVENTIONAL | Low-carbohydrate and high-carbohydrate diets |
| NCT00175084 | Effect of Dietary Amino Acid Profile on Lipoprotein Metabolism, Vascular Reactivity and Inflammatory Markers | COMPLETED | INTERVENTIONAL | Comparison of dietary protein amino acid profile |
| NCT02503865 | Phase 1-2 Study of Development of Rational Ways of Medical and Non-medical Treatment Methods for Metabolic Syndrome | COMPLETED | INTERVENTIONAL | Xenical, Pionorm, Diroton, Diltiazem, Atorvastatin, "Analimentary detoxication" |
| NCT00654485 | A 12 Week Randomized, Double-Blind, Force-Titration, Parallel Group, Multi Centre, Phase IIIb Study to Compare the Efficacy of Rosuvastatin With Atorvastatin and Placebo in the Treatment of Non-Diabetic, Non-Atheroscleric, Metabolic Syndrome Subjects With Raised LDL-C and a 10 Year Risk of CHD >10% | COMPLETED | INTERVENTIONAL | Rosuvastatin, Atorvastatin |
| NCT00356785 | Body Compositional and Endocrine-Metabolic Changes by Long-Term Lifestyle Intervention With Health Education, Diet (Almased®), Physical Activity or a Combination of Diet and Physical Activity in Overweight and Obese Persons. | COMPLETED | INTERVENTIONAL | health education, food supplementation, food supplementation combined with physical activity program |
| NCT07431593 | Clinical Significance and Prognostic Value of Systemic Immune Inflammation Index and Systemic Inflammation Response Index in Obesity and Associated Metabolic Complications | RECRUITING | OBSERVATIONAL | Nutritional counselling |
| NCT06889454 | The Effect of Different Treatment Options on Markers of Vascular, Myocardial and Endothelial Function in Women With Polycystic Ovary Syndrome and the Association With Metabolic and Hormonal Abnormalities of the Syndrome | RECRUITING | OBSERVATIONAL | GLP-1 receptor agonist, Oral contraceptive, Metformin |
| NCT04040777 | Cardiometabolic Risk Factors Registry | RECRUITING | OBSERVATIONAL | |
| NCT07567378 | Cartilage, Arthropathy and Imaging Under Tirzepatide in Zone-stratified Cohorts (CARTIZ): A Prospective Observational Multi-Institutional Registry of the VAT-Articular-Cardiac-Aging Axis in Adults Exposed to Tirzepatide in Mexico, With Quantitative Knee Cartilage T2 Mapping, Cardiac CT Epicardial Adipose Tissue Radiomic Phenotyping, HLA Stratification, Longitudinal Multi-Frequency Bioimpedance Body Composition, and a Prespecified Surgical Tissue Acquisition Subcohort | NOT YET RECRUITING | OBSERVATIONAL | Tirzepatide |
| NCT07357714 | Longitudinal Study on Urinary Function and Multimorbidity Risks Among Beijing Community-dwelling Elderly UFMR-BCE Longitudinal Study | NOT YET RECRUITING | OBSERVATIONAL |
Genetic associations (0)
None linked.